PMA device
Covera Vascular Covered Stent
C.R. Bard, Inc. · System, Endovascular Graft, Arteriovenous (Av) Dialysis Access Circuit Stenosis Treatment (PFV, Class III) · First FDA decision Jul 30, 2018, newest Mar 24, 2022Kidney failure and dialysisVascular access
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
5
PMA pathway
Device trials
5
Naming "Covera"
MAUDE reports
570
Brand "Covera", since 2015
PubMed studies
36
Mentioning "Covera"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Covera Vascular Covered Stent
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 5 of 5 decisions filed under this name.
- Covera Vascular Covered StentPMA supplement
P170042-S011 · Decided Mar 24, 2022 · 216 days after receipt · Normal 180 Day Track No User Fee
Device type: System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatment (PFV) · Cardiology
- Covera Vascular Covered StentPMA supplement
P170042-S005 · Decided Oct 7, 2020 · 177 days after receipt · Normal 180 Day Track No User Fee
Device type: System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatment (PFV) · Cardiology
- Covera Vascular Covered StentPMA supplement
P170042-S003 · Decided Oct 31, 2019 · 213 days after receipt · Normal 180 Day Track No User Fee
Device type: System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatment (PFV) · Cardiology
2 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Physician's Office within an Institution Coverage of Services and Supplies Incident to a Physician's ServicesNational determinationOn the books70.3Updated Jun 12, 2020
- Drugs and Biologicals, Coverage of, for Label and Off-Label UsesLocal determinationIn effectL33394Wellpoint FederalUpdated Jul 16, 2026
- Psychological Services Coverage under the Incident to Provision for Physicians and Non-physiciansLocal determinationIn effectL34539CGS Administrators, LLCUpdated Apr 2, 2026
- Erythropoiesis Stimulating Agents (ESAs) for Treatment of Anemia in Adults with CKD Including Patients on Dialysis and Patients not on DialysisNational analysisReview closedCAG-00413NUpdated Sep 17, 2026
- Hemodialysis for Treatment of SchizophreniaNational determinationOn the books130.8Updated Dec 2, 2002
- Dialysis Access MaintenanceLocal determinationIn effectL34062CGS Administrators, LLCUpdated Feb 20, 2026
- Non-Invasive Peripheral Venous Vascular and Hemodialysis Access StudiesLocal determinationIn effectL35751WPS Insurance CorporationUpdated Feb 20, 2026
- Application of Skin Substitute Grafts for Treatment of DFU and VLU of Lower ExtremitiesLocal determinationIn effectL36377First Coast Service Options, Inc.Updated Nov 21, 2019
Clinical trials
Device studies on ClinicalTrials.gov that name "Covera", any status and sponsor, newest update first.
C. R. BardPublic (BDX)
NCT04261686 · 100 participants · Start Jul 3, 2020 · Primary completion Sep 16, 2025
Device: Covera Vascular Covered Stent · For: Arteriovenous Fistula
Sites: Phoenix, Arizona; New Haven, Connecticut; Westmont, Illinois · 11 sites in all
- COvera in BRAnch RegistryCompleted
IRCCS San RaffaeleAcademic, hospital or other
NCT04598802 · 300 participants · Start Oct 16, 2020 · Primary completion Oct 30, 2022
Device: covered stent · For: Aneurysm
Sites: Hamburg, Germany; Munich, Germany; Asti, Italy · 33 sites in all
- Clinical Study of the BARD® COVERA™ Arteriovenous (AV) Stent GraftPivotal-lookingCompleted
C. R. BardPublic (BDX)
NCT02649946 · 280 participants · Start Jun 2016 · Primary completion Aug 2018
Device: Covera Vascular Covered Stent following PTA · For: Stenosis; Restenosis
Sites: Tempe, Arizona; Laguna Hills, California; Englewood, Colorado · 24 sites in all
2 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Covera", and for the whole product code for context.
This brand
570 reports: 337 malfunction, 226 injury, 7 death
Whole product code PFV
2,805 reports: 1,911 malfunction, 863 injury, 31 death
Newest reports for this brand
Angiomed GmbH & Co. Medizintechnik KG
9681442-2026-00261 · Received Oct 30, 2026 · Event dated Oct 9, 2026
Device type: System, Endovascular Graft, Arteriovenous (Av) Dialysis Access Circuit Stenosis Treatment (PFV)
Device problem as coded: Positioning Failure; Failure to Advance
Patient problem as coded: Rupture; Swelling/ Edema
- Covera Vascular Covered StentMalfunction
Angiomed GmbH & Co. Medizintechnik KG
9681442-2026-00253 · Received Oct 26, 2026 · Event dated Oct 6, 2026
Device type: System, Endovascular Graft, Arteriovenous (Av) Dialysis Access Circuit Stenosis Treatment (PFV)
Device problem as coded: Material Deformation
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
Angiomed GmbH & Co. Medizintechnik KG
9681442-2026-00251 · Received Oct 22, 2026 · Event dated Oct 1, 2026
Device type: System, Endovascular Graft, Arteriovenous (Av) Dialysis Access Circuit Stenosis Treatment (PFV)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Numbness
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Covera"[tiab]. The summary above synthesizes these.
- Comparison of bridging stent grafts in branched endovascular aortic repair.
Migliari M, Leone N, Veraldi GF, et al. · J Vasc Surg · 2024Observational Study, Multicenter Study
- Midterm results on a new self-expandable covered stent combined with branched stent grafts: Insights from a multicenter Italian registry.
Bertoglio L, Grandi A, Veraldi GF, et al. · J Vasc Surg · 2023Multicenter Study, Research Support, Non-U.S. Gov't
- Patency and Durability of Stent Grafts Placed in the Dialysis Circuit Cannulation Zone.
Aronhime S, Timokhin A, Balan S, et al. · J Vasc Interv Radiol · 2024
- Stent-Graft Placement for Hepatic Arterial Hemorrhage after Pancreaticobiliary Surgery: Long-Term Clinical Outcomes.
Kim Y, Kim JH, Kim JH, et al. · J Vasc Interv Radiol · 2024
- Innominate artery aneurysm in behcet disease; report of one case.
Mozafar M, Najari D, Refaei M, et al. · Int J Surg Case Rep · 2024Case Reports
- Endovascular repair of bilateral sciatic artery aneurysm with Covera® self expandable covered stents - case report.
Birck LS, Damazzini R, Nunes WP, et al. · J Vasc Bras · 2023Case Reports
- Stent Grafts Across the Elbow Joint for Access Salvage.
Aronhime S, Avital Y, Balan S, et al. · J Endovasc Ther · 2025
- Mid-term Results of Endovascular Reconstruction of Aortic Bifurcation Using COVERA Stent Graft.
Mastrorilli D, Mezzetto L, Zanetti E, et al. · J Endovasc Ther · 2025
- Management of Epirubicin Extravasation Injuries of the Hand with Debridement and Flap Cover-A Case Series.
Yellinedi R, Damalachervu MR, Nuvvula R, et al. · Indian J Plast Surg · 2023
- Early Experience with the Covera Stent Graft as a Bridging Stent in Branched Thoraco-Abdominal Endovascular Aneurysm Repairs.
Gennai S, Antonello M, Leone N, et al. · J Vasc Interv Radiol · 2019Multicenter Study
- Prospective, Multicenter Clinical Study of the Covera Vascular Covered Stent in the Treatment of Stenosis at the Graft-Vein Anastomosis of Dysfunctional Hemodialysis Access Grafts.
Dolmatch B, Waheed U, Balamuthusamy S, et al. · J Vasc Interv Radiol · 2022Multicenter Study
- Six-Month Outcomes from the Prospective, Multi-Center, Non-Randomized Clinical Study of the COVERA(ࡊ) Arterio VeNous (AV) Stent Graft in the Treatment of Stenosis in the VEnous OutfloW of AV Fistula Access Circuits (AVeNEW PAS).
Dolmatch B, Saber T, Underwood M · Cardiovasc Intervent Radiol · 2025Multicenter Study, Clinical Trial
Other devices of this type
Also filed under product code PFV.
- GORE VIABAHN Endoprosthesis with Heparin Bioactive SurfaceW. L. Gore & Associates, Inc. · PMA 2022
- WRAPSODY® Cell-Impermeable EndoprosthesisMerit Medical Systems, Inc. · PMA 2025
- Fluency Plus Endovascular Stent GraftBard Peripheral Vascular, Inc. · PMA 2017
- Flair Endovascular Stent GraftBard Peripheral Vascular · PMA 2014
- Bard Flair Endovascular Stent GraftBard Peripheral Vascular · PMA 2010
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.